Biomedical applications of nanofibers

被引:186
作者
Leung, Victor [1 ]
Ko, Frank [1 ]
机构
[1] Univ British Columbia, Dept Mat Engn, Vancouver, BC V5Z 1M9, Canada
关键词
nanofibers; biomedical; tissue regeneration; drug delivery; BOMBYX-MORI SILK; MESENCHYMAL STEM-CELLS; IN-VITRO EVALUATION; SILVER NANOPARTICLES; DRUG-DELIVERY; ELECTROSPUN NANOFIBERS; ABDOMINAL ADHESIONS; POLYMER NANOFIBERS; CONTROLLED-RELEASE; CARBON NANOTUBES;
D O I
10.1002/pat.1813
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Nanofiber technology is an exciting area attracting the attention of many researchers as a potential solution to the current challenges in the biomedical field such as burn and wound care, organ repair, and treatment for osteoporosis and various diseases. Nanofibers are attractive in this field for several reasons. First, surface area on nanofibers is much higher compared to bulk materials, which allows for enhanced adhesion of cells, proteins, and drugs. Second, nanofibers can be fabricated into sophisticated macro-scale structures. The ability to fabricate nanofibers allows renewed efforts in developing hierarchical structures that mimic those in animals and human. On top of that, a wide range of polymers can be fabricated into nanofibers to suit different applications. Nanofibers are most commonly fabricated through electrospinning, which is a low cost method that allows control over fiber morphology and is capable of being scaled-up for mass production. This review explored two popular areas of biomedical nanofiber development: tissue regeneration and drug delivery, and included discussions on the basic principles for how nanofibers promote tissue regeneration and drug delivery, the parameters that affect nanofiber performance and the recent progress in these areas. The recent work on biomedical nanofibers showed that the large surface area on nanofibers could be translated into enhanced cell activities, drug encapsulation, and drug release rate control. Furthermore, by optimizing the electrospinning process via adjusting the material choices and fiber orientation, for example, further enhancement in cell differentiation and drug release control could be achieved. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:350 / 365
页数:16
相关论文
共 97 条
[21]   Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia [J].
Ito, A ;
Kuga, Y ;
Honda, H ;
Kikkawa, H ;
Horiuchi, A ;
Watanabe, Y ;
Kobayashi, T .
CANCER LETTERS, 2004, 212 (02) :167-175
[22]   A composite of hydroxyapatite with electrospun biodegradable nanofibers as a tissue engineering material [J].
Ito, Y ;
Hasuda, H ;
Kamitakahara, M ;
Ohtsuki, C ;
Tanihara, M ;
Kang, IK ;
Kwon, OH .
JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2005, 100 (01) :43-49
[23]   Mold-shaped, nanofiber scaffold-based cartilage engineering using human mesenchymal stem cells and bioreactor [J].
Janjanin, Sasa ;
Li, Wan-Ju ;
Morgan, Meredith T. ;
Shanti, Rabie A. ;
Tuan, Rocky S. .
JOURNAL OF SURGICAL RESEARCH, 2008, 149 (01) :47-56
[24]   Modulation of protein release from biodegradable core-shell structured fibers prepared by coaxial electrospinning [J].
Jiang, Hongliang ;
Hu, Yingqian ;
Zhao, Pengcheng ;
Li, Yan ;
Zhu, Kangjie .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2006, 79B (01) :50-57
[25]   Aligned PLGA/HA nanofibrous nanocomposite scaffolds for bone tissue engineering [J].
Jose, Moncy V. ;
Thomas, Vinoy ;
Johnson, Kalonda T. ;
Dean, Derrick R. ;
Nyalro, Elijah .
ACTA BIOMATERIALIA, 2009, 5 (01) :305-315
[26]   How to design a structure able to mimic the arterial wall mechanical behavior? [J].
Jouan, MR ;
Bureau, MN ;
Ajji, A ;
Huneault, MA ;
Mantovani, D .
JOURNAL OF MATERIALS SCIENCE, 2005, 40 (9-10) :2675-2677
[27]   Bioresorbable nanofiber-based systems for wound healing and drug delivery: Optimization of fabrication parameters [J].
Katti, DS ;
Robinson, KW ;
Ko, FK ;
Laurencin, CT .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2004, 70B (02) :286-296
[28]   Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend [J].
Kenawy, ER ;
Bowlin, GL ;
Mansfield, K ;
Layman, J ;
Simpson, DG ;
Sanders, EH ;
Wnek, GE .
JOURNAL OF CONTROLLED RELEASE, 2002, 81 (1-2) :57-64
[29]   Antimicrobial effects of silver nanoparticles [J].
Kim, Jun Sung ;
Kuk, Eunye ;
Yu, Kyeong Nam ;
Kim, Jong-Ho ;
Park, Sung Jin ;
Lee, Hu Jang ;
Kim, So Hyun ;
Park, Young Kyung ;
Park, Yong Ho ;
Hwang, Cheol-Yong ;
Kim, Yong-Kwon ;
Lee, Yoon-Sik ;
Jeong, Dae Hong ;
Cho, Myung-Haing .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2007, 3 (01) :95-101
[30]   Alginate fibres modified with unhydrolysed and hydrolysed chitosans for wound dressings [J].
Knill, CJ ;
Kennedy, JF ;
Mistry, J ;
Miraftab, M ;
Smart, G ;
Groocock, MR ;
Williams, HJ .
CARBOHYDRATE POLYMERS, 2004, 55 (01) :65-76